Skip to content

Efficacy of corticosteroid and acyclovir in Bell´s palsy

Comparison of the effects of combination therapy of Prednisolone and Acyclovir with Prednisolone alone in Bell´s palsy patients aged 2-18 years

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2012062210087N1
Enrollment
100
Registered
2013-11-10
Start date
2011-09-20
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

bell palsy. Bell palsy

Interventions

Intervention 1: The first group Prednisolone 2 mg per kg of body weight to be given seven days. Intervention 2: The second group of Prednisolone at a dose of 2 mg per kg of body weight, Acyclovir tabl
Treatment - Drugs
The first group Prednisolone 2 mg per kg of body weight to be given seven days
The second group of Prednisolone at a dose of 2 mg per kg of body weight, Acyclovir tablets of 20 mg per kg of body weight should be given for seven days.

Sponsors

Vice chancellor for research, Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: 1. aged 2 to 18 years 2. Patients who have just seventh nerve palsy. 3. No more than three days after the symptoms have passed. After investigating the specific cause is not found for seven nerve palsy. Exclusion Criteria: 1. Patients with paralysis of the seventh nerve palsy, other cranial nerves are. 2. Be over the last three days of onset of symptoms. 3. After examining the specific cause is found for paralysis. 4. The last two weeks of treatment is anti-herpetic received. 5. Be sensitive to acyclovir

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of palsy according to house_brackmann scale. Timepoint: 1 and 2 month after treatment. Method of measurement: house_brackmann scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSara Sheikhvesi

Zahedan University of Medical Science

s_sheikhveisi@yahoo.com+98 54 1242 1638

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026